Drug intelligence / Profile preview

Sweet Dream Oral Liquid

Development stage
Unknown
Lead developer
Wuhan Mental Health Center
Administration
Oral
01

Overview

Sweet Dream Oral Liquid (Meimeng Koufuye) is a Traditional Chinese Medicine (TCM) formulation widely used in China for the treatment of insomnia, anxiety, and neurasthenia. It is composed of multiple herbal extracts, including *Radix Rehmanniae*, *Radix Angelicae Sinensis*, and *Semen Ziziphi Spinosae*. In clinical research, it is being evaluated as an adjunctive therapy for patients with schizophrenia to alleviate side effects associated with long-term atypical antipsychotic use, such as hyperprolactinemia, sexual dysfunction, extrapyramidal symptoms, and cognitive impairment. The therapeutic effects are attributed to its ability to regulate the central nervous system, potentially through the modulation of GABAergic and serotonergic pathways, providing sedative, hypnotic, and neuroprotective benefits.

Brand names
Sweet Dream Oral LiquidMeimeng Koufuye
Other names
Meimeng Oral Liquid
02

Targets

GABRR (GABA-A receptor subunit rho)5-HT (Serotonin receptors)

Beyond the preview

Go deeper on Sweet Dream Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sweet Dream Oral Liquid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call